Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli

Journal of Clinical Microbiology

Volumn 34, Issue 4, 1996, Pages 908-911

  Jacoby, George A ^a   Han, Paula ^b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; SULBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; ESCHERICHIA COLI; GENE MUTATION; KLEBSIELLA PNEUMONIAE; PLASMID; PRIORITY JOURNAL;

EID: 0029879460     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.4.908-911.1996     Document Type: Article

References (25)

1. Arstila, T., G. A. Jacoby, and P. Huovinen. 1993. Evaluation of five different methods to prepare bacterial extracts for the identification of β-lactamases by isoelectric focusing J. Antimicrob. Chemother. 32:809-816.
2. Bush, K., and S. B. Singer. 1989. Biochemical characteristics of extended broad spectrum β-lactamases Infection 17:429-433.
3. Coetzee, J. N., N. Datta, and R. W. Hedges. 1972. R factors from Proteus rettgeri. J Gen Microbiol. 72:543-552.
4. Jacoby, G. A. 1994. The genetics of extended-spectrum beta-lactamascs. Eur. J. Clin. Microbiol. Infect Dis. 13(Suppl. 1):2-11.
5. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum β-lactamases. Antimicrob. Agents Chemother 35:1697-1704.
6. Jacoby, G. A., and L. Sutton. 1991. Properties of plasmids responsible for extended-spectrum β-lactamase production. Antimicrob. Agents Chemother. 35:164-169.
7. Katsanis, G. P., J. Spargo, M. J. Ferraro, L. Sutton, and G. A. Jacoby. 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases J Clin. Microbiol. 32:691-696
8. Martínez-Martínez, L., S. Hernández-Allés, S. Albertí, J. M. Tomás, V. J. Benedí, and G. A. Jacoby. 1996. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 40:342-348
9. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of ́-lactamases. J. Gen. Microbiol. 88:169-178.
10. Medeiros, A. A., M. Cohenford, and G. A. Jacoby. 1985 Five novel plasmid-determined ́-lactamases. Antimicrob- Aaents Chemother. 27:715-719
11. Meyer, K. S., C. Urban, J. A. Eagan, B. J. Berger, and J. J. Rahal. 1993 Nosocomial outbreak of Kiebsiella infection resistant to late-generation cephalosporins. Ann. Intern. Med. 119:353-358.
12. National Committee for Clinical Laboratory Standards. 1990. Performance standards for antimicrobial disk susceptibility tests, 4th ed. Approved standard M2-A4 (M100-54). National Committee for Clinical Laboratory Standards, Villanova, Pa
13. Normark, S., T. Grundstrom, and S. Bergstrom. 1980. Susceptibility to penicillins and cephalosporins in ́-lactamase producing strains of E. coli and relative amount of ́-lactamase produced from these strains Scand. J Infect. Dis. Suppl 25:23-29
14. Payne, D. J., and S. G. B. Amyes. 1991. Transferable resistance to extended spectrum ́-lactams. a major threat or a minor inconvenience? J. Antimicrob. Chemother 27:255-261.
15. Philippon, A., G. Fournier, G. Paul, G. Vedel, and P. Névot. 1988. Détection et distribution des béta-lactamases á spectre élargi chez les entérobacténes. Méd Mal. Infect 12:869-876.
16. Philippon, A., R. Labia, and G. Jacoby. 1989. Extended-spectrum β-lactamases. Antimicrob Agents Chemother. 33:1131-1136.
17. Takahashi, I., T. Sawai, T. Ando, and S. Yamagishi. 1980. Cefoxitin resistance by a chromosomal cephalosporinase m Escherichia coli. J. Antibiot 33:1037-1042
18. Thomson, K. S. 1995. Improved detection of extended-spectrum β-lactamases (ESBLs) from disk diffusion susceptibility tests, abstr. C-87, p 16 In Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C
19. Spitzer, E. D., and S. G. Spitzer. 1992. Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans. J. Clin. Microbiol. 30:1094-1097.
20. Spitzer, E. D., S. G. Spitzer, L. F. Freundlich, and A. Casadevall. 1993. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341:595-596.
21. St. Germain, G., G. Noel, and K. J. Kwon-Chung. 1988. Disseminated cryptococcosis due to Cryptococcus neoformans var. gattii in a Canadian patient with AIDS. Eur. J. Clin. Microbiol. Infect. Dis. 7:587-588.
22. Sugar, A. M. 1991. Overview: cryptococcosis in the patient with AIDS. Mycopathologia 114:153-157.
23. Tibayrenc, M., F. Kjellberg, J. Arnaud, B. Oury, S. F. Breniere, M.-L. Darde, and F. J, Ayala. 1991. Are eukaryotic microorganisms clonal or sexual? A population genetics vantage. Proc. Natl. Acad. Sci. USA 88:5129-5133.
24. Varma, A., and K. J. Kwon-Chuog. 1989. Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans. J. Gen. Microbiol. 135:3353-3362.
25. Varma, A., D. Swiane, F. Staib, J. E. Bennett, and K. J. Kwon-Chung. 1995. Diversity of DNA fingerprints in Cryptococcus neoformans. J. Clin. Microbiol. 33:1807-1814.